13D Filings
Home
FAQ
Lifecore Biomedical, Inc.
LFCR
Amendment
Ownership

6.74%

Total Shares

2,712,472

Issuer CIK

1005286

Event Date

Jun 29, 2026

Accepted

Jul 2, 2026, 05:15 PM

SEC EDGARView Original Filing
Reporting Persons (7)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
22NW Fund, LP
Partnership
6.74%2,712,4722,712,4720
22NW, LP
Partnership
6.74%2,712,4722,712,4720
22NW Fund GP, LLC
Other
6.74%2,712,4722,712,4720
22NW GP, Inc.
CO
6.74%2,712,4722,712,4720
Aron R. English
Individual
6.74%2,712,4722,712,4720
Bryson O. Hirai-Hadley
Individual
0.00%5835830
Nathaniel Calloway
Individual
0.00%000
Disclosure Items (3)

Security Title

Common Stock, par value $0.001 per share

Issuer Name

Lifecore Biomedical, Inc.

Issuer Address

3515 Lyman Boulevard, Chaska, MN, 55318

Item 4 is hereby amended to add the following: The Reporting Persons are holders of shares of Series A Convertible Preferred Stock, par value $0.001 per share (the "Series A Preferred Stock"), of the Issuer, with rights as provided in the Certificate of Designations, Preferences, and Rights of Series A Convertible Preferred Stock of the Issuer (the "Certificate of Designations"). Section 8 of the of the Certificate of Designations, provides that from and after June 29, 2026, each holder of Series A Preferred Stock shall have the right to require that the Issuer redeem all or any portion of the conversion amount of such Holder's Series A Preferred Stock then outstanding, with such redemption to occur on the date which is the one hundred eightieth (180th) day, or the next business day if such date is not a business day, from the date the holder of Series A Preferred Stock gives notice to the Issuer. Any such redemption shall be pursuant to the terms of the Certificate of Designations. On June 30, 2026, the Reporting Persons submitted an optional redemption notice to the Issuer pursuant to Section 8 of the Certificate of Designations for 19,068.833524 shares of Series A Preferred Stock, plus all accrued and unpaid dividends, as well as all shares of Series A Preferred Stock paid as PIK dividends following June 30, 2026, representing the Reporting Persons' entire holdings of Series A Preferred Stock. The redemption date as set forth in the notice is December 28, 2026. Upon the occurrence of the redemption, the Reporting Persons' entire holdings of Series A Preferred Stock shall be purchased by the Issuer for cash and the Reporting Persons shall not hold any shares of Series A Preferred Stock. In its Form 10-Q filed May 6, 2026, the Issuer stated: "To make such cash redemption payments the Company would be required to obtain consent to such redemption payments or waiver of the restriction on cash dividends and/or redemptions set forth in each of the Company's credit agreements." 22NW believes that if the Issuer imposes this restriction on the redemption of its shares of Series A Preferred Stock it will be in contravention of the Certificate of Designations. 22NW intends to file a motion with the Supreme Court of the State of New York, County of New York to amend its outstanding Complaint against the Issuer and certain former directors and officers of the Issuer to, among other things, include a claim that when the Issuer entered into its current credit agreements in May 2023 it breached that certain Securities Purchase Agreement dated as of January 9, 2023, under which 22NW and other investors purchased the Series A Preferred Stock.

Percentage of Class

Items 5(a) - (b) are hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 40,220,625 Shares outstanding, consisting of (i) 37,509,407 shares of Common Stock as of April 29, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 6, 2026, plus (ii) 2,711,218 Shares issuable upon the conversion of certain shares of Series A Preferred Stock. As of the date hereof, 22NW Fund directly beneficially owned 2,712,472 Shares, including 2,711,218 Shares issuable upon the conversion of certain shares of Series A Preferred Stock, constituting approximately 6.74% of the Shares outstanding. As of the date hereof, Mr. Hirai-Hadley directly beneficially owned 583 Shares, constituting less than 1% of the Shares outstanding. By virtue of his position as a partner of 22NW, Mr. Hirai-Hadley may be deemed to beneficially own the 2,712,472 Shares beneficially owned by 22NW Fund, constituting approximately 6.74% of the Shares outstanding, although he disclaims beneficial ownership of such shares. As of the date hereof, Mr. Calloway directly beneficially owned zero Shares, constituting 0% of the Shares outstanding. By virtue of his position as a partner of 22NW, Mr. Calloway may be deemed to beneficially own the 2,712,472 Shares beneficially owned by 22NW Fund, constituting approximately 6.74% of the Shares outstanding, although he disclaims beneficial ownership of such shares. 22NW, as the investment manager of 22NW Fund, may be deemed to beneficially own the 2,712,472 Shares beneficially owned by 22NW Fund, constituting approximately 6.74% of the Shares outstanding. 22NW GP, as the general partner of 22NW Fund, may be deemed to beneficially own the 2,712,472 Shares beneficially owned by 22NW Fund, constituting approximately 6.74% of the Shares outstanding. 22NW Inc., as the general partner of 22NW, may be deemed to beneficially own the 2,712,472 Shares beneficially owned by 22NW Fund, constituting approximately 6.74% of the Shares outstanding. Mr. English, as the portfolio manager of 22NW, manager of 22NW GP and president and sole shareholder of 22NW Inc., may be deemed to beneficially own the 2,712,472 Shares beneficially owned by 22NW Fund, constituting approximately 6.74% of the Shares outstanding. Each Reporting Person may be deemed to be a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and such group may be deemed to beneficially own the 2,712,472 Shares owned in the aggregate by all of the Reporting Persons, constituting approximately 6.74% of the outstanding Shares. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Exchange Act, the beneficial owners of any securities of the Issuer he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

Number of Shares

In the past sixty days, the Reporting Persons have not made any transactions in the Issuer's common stock, except that they have submitted the optional redemption notice discussed in Item 4.